Last reviewed · How we verify
Progesterone 200 MG — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Progesterone 200 MG (Progesterone 200 MG) — Instituto Bernabeu.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Progesterone 200 MG TARGET | Progesterone 200 MG | Instituto Bernabeu | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Progesterone 200 MG CI watch — RSS
- Progesterone 200 MG CI watch — Atom
- Progesterone 200 MG CI watch — JSON
- Progesterone 200 MG alone — RSS
Cite this brief
Drug Landscape (2026). Progesterone 200 MG — Competitive Intelligence Brief. https://druglandscape.com/ci/progesterone-200-mg. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing